## Mutants of a determinant of hepatitis B surface antigen (HBsAg) identified in vaccinated children pose a potential threat to long-term success of vaccination programs. We examined the mutants of a determinant (residues 110-160) of HBsAg in hepatitis B virus (HBV) DNA-positive children identifie
Decline of hepatitis B carrier rate in vaccinated and unvaccinated subjects: Sixteen years after newborn vaccination program in Taiwan
β Scribed by Hans Hsienhong Lin; Li-Yu Wang; Chi-Tan Hu; Shih-Che Huang; Lu-Chin Huang; Sherry S.J. Lin; Yu-Ming Chiang; Tso-Tsai Liu; Chien-Lin Chen
- Book ID
- 102384342
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 75 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0146-6615
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Taiwan was an endemic area for hepatitis B virus (HBV) infection, and related liver diseases cause a significant drain of public resources. To control the endemic, a nationβwide newborn vaccination program was started in 1985. We reviewed the results of the annual survey for HBV surface antigen (HBsAg) performed in freshmen class of two high schools in Hualien, eastern Taiwan, from 1991 to 2001. A total of 10,194 students, most of them 15 years old, were tested for serum HBsAg using enzyme immunoassays. There is a significant trend (Pβ<β0.0001) of decreasing HBsAg carrier rate from 20.3 to 4.4% in males and 14.3% to 2.4% in females, respectively, over 11 years. The HBsAg carrier rate was 16.0β20.3% in students surveyed during 1991β1993 (born more than 6 years before the start of the national vaccination program), which decreased to 7.7β11.9% during 1994β1999 (born 1β6 years before the program). It further declined to 4.7% and 3.4% in 2000 and 2001 (born after the start of the program). The HBsAg carrier rate in male students was significantly higher than that in female students in most of the years. The HBV newborn vaccination program not only successfully prevented most of the perinatal transmission of HBV but also reduced horizontal transmission of HBV to children born up to 6 years before the start of the program. Also, the protection persisted for at least 15 years. J. Med. Virol. 69:471β474, 2003. Β© 2003 WileyβLiss, Inc.
π SIMILAR VOLUMES
## Abstract The emergence of mutations in the hepatitis B virus (HBV) __S__ gene has threatened the longβterm success of vaccination programs since the worldwide introduction of effective vaccines against hepatitis B. This study was conducted on 5,407 children (0β8 years old) in eastern China in 20